We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.49%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$58.1B
AUM Growth
+$5.28B
(+10%)
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
14.06%
Holding
4,799
New
857
Increased
1,497
Reduced
1,529
Closed
854
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$701M |
| 2 |
Pinduoduo
PDD
|
+$159M |
| 3 |
CrowdStrike
CRWD
|
+$152M |
| 4 |
UnitedHealth
UNH
|
+$143M |
| 5 |
SPDR Gold Trust
GLD
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.17B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$240M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 5 |
Ulta Beauty
ULTA
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.49% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Healthcare | 4.58% |
| 4 | Financials | 4.54% |
| 5 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
Barclays
BCS
$94.1B
| $110K | ﹤0.01% |
11,591
-15,374
| -57% | -$126K |
|
3777
LiveOne
LVO
$66M
| $109K | ﹤0.01% |
5,604
-472
| -8% | -$7.5K |
|
3778
Bolt Biotherapeutics
BOLT
$7.36M
| $109K | ﹤0.01% |
3,901
-88
| -2% | -$2.04K |
|
|
LAR
3779
CALL
Lithium Argentina AG
LAR
$958M
| $108K | ﹤0.01% |
20,000
| – | – |
|
3780
loanDepot
LDI
$548M
| $106K | ﹤0.01% |
41,029
-43,457
| -51% | -$117K |
|
3781
OraSure Technologies
OSUR
$273M
| $106K | ﹤0.01% |
17,234
-319
| -2% | -$2.32K |
|
3782
Abeona Therapeutics
ABEO
$345M
| $105K | ﹤0.01% |
14,520
+4,520
| +45% | +$28.6K |
|
|
SHCO
3783
DELISTED
Soho House & Co
SHCO
| $105K | ﹤0.01% |
+18,495
| New | +$112K |
|
|
TIGR
3784
UP Fintech Holding
TIGR
$845M
| $105K | ﹤0.01% |
+30,461
| New | +$121K |
|
3785
Apyx Medical
APYX
$165M
| $104K | ﹤0.01% |
76,118
-49,258
| -39% | -$105K |
|
3786
CALL
CytomX Therapeutics
CTMX
$705M
| $102K | ﹤0.01% |
+47,000
| New | +$86.7K |
|
3787
Outset Medical
OM
$74.9M
| $102K | ﹤0.01% |
3,074
-5,577
| -64% | -$282K |
|
3788
Energy Services of America
ESOA
$297M
| $102K | ﹤0.01% |
+12,322
| New | +$90.7K |
|
|
PTN
3789
Palatin Technologies
PTN
$13.7M
| $102K | ﹤0.01% |
+1,087
| New | +$159K |
|
3790
Aveanna Healthcare
AVAH
$2.06B
| $101K | ﹤0.01% |
40,491
+18,054
| +80% | +$43.6K |
|
3791
Compass Therapeutics
CMPX
$373M
| $101K | ﹤0.01% |
50,812
-37,908
| -43% | -$65.5K |
|
|
TRUE
3792
DELISTED
TrueCar
TRUE
| $100K | ﹤0.01% |
+29,573
| New | +$103K |
|
|
WW
3793
DELISTED
WW International
WW
| $99.7K | ﹤0.01% |
53,915
-97,331
| -64% | -$387K |
|
3794
Planet Labs
PL
$7.3B
| $98.9K | ﹤0.01% |
38,785
+18,259
| +89% | +$41.3K |
|
3795
Televisa
TV
$1.45B
| $97.8K | ﹤0.01% |
30,564
-88,687
| -74% | -$269K |
|
3796
GDS Holdings
GDS
$6.34B
| $96.2K | ﹤0.01% |
+14,461
| New | +$97.9K |
|
3797
Alto Ingredients
ALTO
$360M
| $95.9K | ﹤0.01% |
43,970
+31,721
| +259% | +$66.9K |
|
3798
Neuronetics
STIM
$120M
| $95.7K | ﹤0.01% |
+20,098
| New | +$70.6K |
|
3799
Rockwell Medical
RMTI
$26.2M
| $94.6K | ﹤0.01% |
5,699
+3,247
| +132% | +$47.2K |
|
|
NKLA
3800
PUT
DELISTED
Nikola Corporation Common Stock
NKLA
| $93.6K | ﹤0.01% |
3,000
| – | – |
|
Similar funds
Squarepoint's Q1 2024 Portfolio in Review
As of Q1 2024, Squarepoint held 4,799 positions worth $58.1B, up 10% from $52.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Squarepoint's Q1 2024 filing shows 857 new, 1,497 increased, 1,529 reduced and 854 closed positions. Its largest new stake was The Gap Inc: 3,316,943 shares worth $91.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 9.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Squarepoint's largest Q1 2024 buy was The Gap Inc: 3,316,943 shares worth $91.4M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q1 2024, an estimated $701M increase.
- Squarepoint's biggest Q1 2024 reduction was Invesco QQQ Trust, cutting an estimated $240M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $1.17B.
- Squarepoint's ten largest holdings make up 14% of its $58.1B portfolio in Q1 2024.
- Squarepoint opened 857 new positions and closed 854 in Q1 2024.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $58.1B.
Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.